Cohort study

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair

JACC Cardiovasc IntervPublished

  • Registry-based cohort study
  • multicentre registry

Authors' conclusion

PH is an important outcome predictor in patients undergoing T-TEER for relevant TR. In contrast to previous studies, no significant differences were observed for patients with precapillary and postcapillary PH in terms of survival free from HFH.

Study context

Population
Patients undergoing T-TEER for relevant tricuspid regurgitation (TR) (EuroTR registry, 2016–2023) with invasive systolic pulmonary artery pressure (sPAP) by right heart catheterization
Participants
1,230 patients
Exposure
Elevated vs lower sPAP; precapillary vs postcapillary pulmonary hypertension (PH)
  • sPAP >46 mm Hgn = 526
Outcome
Combined death or HF hospitalization (also procedural TR reduction and NYHA class improvement)
Follow-up
2 years

Main finding

Death or HFH

Hazard ratio

1.027

95% CI 1.003–1.052

P = 0.030

Increasing sPAP
HR 1.027 (95% CI 1.003–1.052); P = 0.030

As reported in the abstract

Observational data: associations, not effects.

Further findings

Optimized sPAP threshold for prediction of death or heart failure hospitalization (HFH) (sensitivity analysis)

Optimized sPAP threshold
46 mm Hg
Elevated sPAP (>46 mm Hg) observed
526 patients (42.8%)
Elevated sPAP associated with more severe HF symptoms at baseline and follow-up

NYHA class and TR severity

NYHA class significantly improved and TR severity significantly reduced irrespective of PH

Original publication

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair. JACC Cardiovasc Interv. Published 28 October 2024. doi:10.1016/j.jcin.2024.10.023

Summarised from the published abstract; every number is checked against it